Uso de agentes antipsicóticos y enfermedad tromboembólica venosa recurrente

Contenido principal del artículo

Augusto Ferraris

Downloads

Download data is not yet available.

Detalles del artículo

Sección

El Hospital Italiano en Medline 

Cómo citar

1.
Ferraris A. Uso de agentes antipsicóticos y enfermedad tromboembólica venosa recurrente. Rev Hosp Ital B.Aires [Internet]. 2020 Mar. 30 [cited 2026 Apr. 27];40(1):33. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/496

Referencias

Ishiguro C,Wang X, Li L, et al. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014; 23:1168-75. DOI: https://doi.org/10.1002/pds.3699

Ferraris A, Szmulewicz AG, Vázquez FJ, et al. Antipsychotic use among adult outpatients and venous thromboembolic disease: a retrospective cohort study. J Clin Psychopharmacol. 2017; 37(4):405-11. DOI: https://doi.org/10.1097/JCP.0000000000000738

Mollard LM, Le Mao R, Tromeur C, et al. Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study. Eur J Intern Med. 2018; 52:22-27. DOI: https://doi.org/10.1016/j.ejim.2018.02.030

Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010; 341:c4245. DOI: https://doi.org/10.1136/bmj.c4245

Schmedt N, Garbe E. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol. 2013; 33:753-8. DOI: https://doi.org/10.1097/JCP.0b013e3182a412d5

Wu CS, Lin CC, Chang CM, et al. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry. 2013; 4:918-24. DOI: https://doi.org/10.4088/JCP.12m08117